COMMUNIQUÉS West-GlobeNewswire

-
Best Skin Tag Remover 2025: Revitag Review & Top Skin Tag Removal Tips
11/05/2025 -
Akero Therapeutics et HistoIndex présentent de nouvelles analyses de l’essai de phase IIb HARMONY lors de présentations orales et d’affiches lors du congrès 2025 de l’EASL
11/05/2025 -
Best Probiotic for Bloating, Gas, and Constipation: Top Probiotic Supplements for Gut Health to Reduce Bloating, Indigestion & Flatulence (YourBiology)
11/05/2025 -
Best Vyvanse Alternative Over the Counter for ADHD - Natural Vyvanse Substitute - Noocube
10/05/2025 -
Akero Therapeutics annonce la publication de l’essai de phase 2b SYMMETRY dans le New England Journal of Medicine
10/05/2025 -
MEDVi Under Review: Best GLP-1 Semaglutide & Terzepatide Compound Solution for Personalized Weight Loss
10/05/2025 -
Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis
10/05/2025 -
Sumatra Slim Belly Tonic Reviews: 2025 Real User Reviews Analyzed & Verified (Blue Tonic for Weight Loss)
10/05/2025 -
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
10/05/2025 -
4 Best Supplements for Muscle Growth in 2025 - Legal Steroid Alternatives & Bodybuilding Supplements for Bulking and Strength - Wolfson Brands
10/05/2025 -
Best Fat Burners For Men 2025: Top Weight Loss Pills & Supplements For Fast Fat Loss - Wolfson Brands Ltd
10/05/2025 -
6 Best Fat Burners For Women: Top Over the Counter and Online Pills and Fat Burning Supplements For Women Weight Loss In 2025 - Wolfson Brands
10/05/2025 -
Activists Mark Luigi Mangione’s Birthday With Aerial Protest as Times Square Billboard on Jury Rights Explodes Online
10/05/2025 -
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/05/2025 -
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09/05/2025 -
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/05/2025 -
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
09/05/2025 -
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/05/2025 -
Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
09/05/2025
Pages